Cytognomix

About Cytognomix

Cytognomix is a laboratory and research company located on North Centre Rd in the Masonville neighbourhood of London. The business serves research, translational, and clinical laboratories by providing advanced genomic bioinformatic technologies to find and validate mutations and gene signatures. The company offers a suite of genome interpretation products, most notably its patented MutationForecaster® web portal. This platform allows for the analysis, comparison, and management of genetic variant data, including coding, non-coding, and copy number variants. Specific software pipelines available for use on exomes, gene panels, or complete genomes include Shannon transcription factor and splicing pipelines, ASSEDA, and Veridical. Users can also utilize the Cytognomix User Variation Database, the Variant Effect Predictor, and CytoVisualization Analytics to select predicted mutations by phenotype. For those who prefer not to perform their own analyses, the company provides a Bespoke Analysis Service. Cytognomix also specializes in automated radiation biodosimetry and predictive modeling for chemotherapy. They offer the Automated Dicentric Chromosome Identifier and Dose Estimator (ADCI), which uses machine learning to identify dicentric chromosomes and estimate radiation exposure. Additionally, the company provides gene signatures derived from machine learning to predict pharmacogenomic responses to 30 different commonly used chemotherapy drugs. Their technical offerings also include single copy genomic technologies, customized genomic microarrays, and ultrahigh resolution FISH probes.